Filing Details
- Accession Number:
- 0000899243-22-016426
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-03 19:25:16
- Reporting Period:
- 2022-04-30
- Accepted Time:
- 2022-05-03 19:25:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605065 | Brian Mcdonough | 28 Esplanade St Helier Y9 JE2 3QA | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-05-02 | 2,060 | $0.00 | 73,644 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2022-04-30 | 6,917 | $0.00 | 75,704 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2022-04-30 | 6,917 | $0.00 | 6,917 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,834 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 53,040 | Indirect | By the McDonough-McGuire Joint Revocable Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $8.00 | 2024-04-29 | 10,000 | 10,000 | Direct | |
| Ordinary Shares | Options to purchase ordinary shares | $0.00 | 2014-11-14 | 2022-08-30 | 40,029 | 40,029 | Direct |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $9.95 | 2024-10-31 | 5,025 | 5,025 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $11.62 | 2025-10-31 | 4,303 | 4,303 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $5.73 | 2026-10-31 | 8,726 | 8,726 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $5.21 | 2027-10-31 | 9,597 | 9,597 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $6.41 | 2028-10-31 | 6,240 | 6,240 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $7.78 | 2029-10-31 | 8,158 | 8,158 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $4.55 | 2030-10-31 | 13,611 | 13,611 | Direct | |
| Ordinary Shares | Ordinary Shares Option (Right to buy) | $2.53 | 2031-10-31 | 24,040 | 24,040 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-04-29 | 10,000 | 10,000 | Direct |
| 2022-08-30 | 40,029 | 40,029 | Direct |
| 2024-10-31 | 5,025 | 5,025 | Direct |
| 2025-10-31 | 4,303 | 4,303 | Direct |
| 2026-10-31 | 8,726 | 8,726 | Direct |
| 2027-10-31 | 9,597 | 9,597 | Direct |
| 2028-10-31 | 6,240 | 6,240 | Direct |
| 2029-10-31 | 8,158 | 8,158 | Direct |
| 2030-10-31 | 13,611 | 13,611 | Direct |
| 2031-10-31 | 24,040 | 24,040 | Direct |
Footnotes
- All 10,000 options have vested and remain exercisable.
- The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
- All 5,025 options have vested and remain exercisable.
- All 4,303 options have vested and remain exercisable.
- All 8,726 options have vested and remain exercisable.
- Restricted Stock Units convert into ordinary shares on a one-for-one basis.
- All 9,597 options have vested and remain exercisable.
- All 6,240 options have vested and remain exercisable.
- The Reporting Person and his spouse are Co-Trustees of their successors in trust, of the McDonough-McGuire Joint Revocable Trust, dated May 14, 2013. The Reporting Person disclaims beneficialownership of these securities except tothe extent of his pecuniary interest therein, and the inclusion of these ordinary shares in this report shall not be deemed an admission of beneficial ownership of all of thereported ordinary shares for purposes of Section 16 or for any other purpose.
- 2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
- All 13,611 options have vested and remain exercisable.
- On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 13,834 have vested and have converted into ordinary shares. The remaining 13,834 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022.
- The options vest and become exercisable on October 31, 2022.
- The sale reported on this Form 4 is a sale to cover taxes arising from the vesting and settlement of RSU awards. This sale is mandated by the Reporting Person's election to fund such taxes by completing a"sell to cover" transaction with a brokerage firm designated by the Issuer.
Billionaire Hedge Funds
